iHumanIH -4.26%50 EPS without NRI is $0.65 as of Mar. 2026. GuruFocus rates IH with a GF Score™ of 50/100 and a GF Value™ of $2.93 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 180 Education companies, iHuman ranks worse than 77.78% on this metric.
iHuman's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was $0.07.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $0.65.
During the past 12 months, iHuman's average earnings per share (NRI) Growth Rate was -51.60% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was -7.80% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for iHuman's EPS without NRI or its related term are showing as below:
IH'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -79.2 Med: -43.5 Max: -7.8
Current: -7.8
During the past 8 years, iHuman's highest 3-Year average Earnings Per Share (NRI) Growth Rate was -7.80% per year. The lowest was -79.20% per year. And the median was -43.50% per year.
IH's 3-Year EPS without NRI Growth Rate is ranked worse than 77.78% of 180
companies
in the Education industry
Industry Median: 7.75
vs IH: -7.80
iHuman's EPS (Diluted) for the
three
months ended in Mar. 2026 was $0.07.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.25.
iHuman's EPS (Basic) for the
three
months ended in Mar. 2026 was $0.07.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.25.
iHuman (NYSE:IH) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
iHuman EPS without NRI Related Terms
iHuman EPS without NRI Historical Data
* Premium members only.
The historical data trend for iHuman's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Education & Training Services subindustry, iHuman's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iHuman PE Ratio without NRI vs Education Industry
For the Education industry and Consumer Defensive sector, iHuman's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where iHuman's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.65
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iHuman (IH) has a EPS without NRI of $0.65 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on iHuman and its competitors. According to the industry distribution chart, iHuman ranks #140 out of 180 companies in the Education industry, placing it in the top 77.8%.
Is iHuman's EPS without NRI too high?
iHuman's current EPS without NRI is $0.65. The Education industry median EPS without NRI is 7.75. iHuman's value of $0.65 is 91.6% below this industry median. Based on the distribution chart, iHuman ranks #140 out of 180 companies in the Education industry, which is in the bottom quartile relative to peers. Overall, iHuman has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iHuman's EPS without NRI compare to STG and SKIL?
According to the Education industry distribution chart, iHuman ranks #140 out of 180 companies for EPS without NRI. This places iHuman in the lower half of its industry. The industry median EPS without NRI is 7.75. iHuman's value of $0.65 is 91.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for an Education company?
The median EPS without NRI among Education companies is 7.75, based on 180 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iHuman's current EPS without NRI of $0.65 is 91.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on iHuman and its competitors. For the Education industry, the median EPS without NRI is 7.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iHuman's current EPS without NRI is $0.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iHuman stock overvalued right now?
Based on GuruFocus' analysis, iHuman (IH) is currently considered Significantly Undervalued. The stock's GF Value™ is $2.93, compared to a current price of $1.41 — trading 52% below its estimated fair value. The current EPS without NRI is $0.65 and 91.6% below the Education industry median of 7.75. iHuman's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For iHuman (IH), the current EPS without NRI is $0.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iHuman (IH) Overvalued in 2026?
Based on GuruFocus' analysis, iHuman stock appears to be undervalued.
The current stock price of $1.41 is trading 52% below its estimated GF Value™ of $2.93.
GuruFocus considers iHuman to be Significantly Undervalued.
Key valuation signals for IH:
EPS without NRI: $0.65
GF Value™: $2.93 vs. price of $1.41 (52% below fair value)
Industry Position: 91.6% below the Education median (#140 of 180)
No single metric tells the full story. See the IH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.
50GF Score
Get the complete analysis for IH
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IH has been successfully added to your 
